Correlation Between Cardio Diagnostics and VistaGen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and VistaGen Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and VistaGen Therapeutics.
Diversification Opportunities for Cardio Diagnostics and VistaGen Therapeutics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cardio and VistaGen is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and VistaGen Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and VistaGen Therapeutics
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 5.4 times more return on investment than VistaGen Therapeutics. However, Cardio Diagnostics is 5.4 times more volatile than VistaGen Therapeutics. It trades about 0.24 of its potential returns per unit of risk. VistaGen Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 29.00 in Cardio Diagnostics Holdings on September 12, 2024 and sell it today you would earn a total of 123.00 from holding Cardio Diagnostics Holdings or generate 424.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. VistaGen Therapeutics
Performance |
| Timeline |
| Cardio Diagnostics |
| VistaGen Therapeutics |
Cardio Diagnostics and VistaGen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and VistaGen Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| VistaGen Therapeutics vs. Synlogic | VistaGen Therapeutics vs. AC Immune | VistaGen Therapeutics vs. Histogen | VistaGen Therapeutics vs. Entera Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |